Consistent with these previous reports, our study found that cisplatin can cause “oncogenic-type” of drug resistance which simultaneously activates STAT3/Snail pathway to make cell aggressive, such as tumor invasion and cancer stem-like capability in ATRT-CisR cells. The gene discussed is STAT3; the disease is neoplasm.